Mizuho Securities Upgrades DepoMed Inc (DEPO) to Buy

May 9, 2016 7:37 AM EDT
Get Alerts DEPO Hot Sheet
Price: $7.30 --0%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 25 | Down: 19 | New: 37
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Mizuho Securities upgraded DepoMed Inc (NASDAQ: DEPO) from Neutral to Buy with a price target of $19.00 (from $18.00), on increased takeout probability.

Analyst Irina Koffler commented, "DEPO posted unimpressive numbers in 1Q:16 and shares got dragged down with the group on Friday. We think there is now an attractive entry point into a stock with some positive momentum and takeout prospects ahead, and we upgrade DEPO to Buy from Neutral. Our PT goes to $19 from $18."

She added, "We previously assigned a 20% probability of takeout to DEPO (at $20/share), coupled with 80% reliance on a ~$17/share DCF value. We are shifting to a 50%/50% probability allocation as we progress closer to the Nucynta/ ER settlement."

For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.

Shares of DepoMed Inc closed at $15.51 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, Hot Upgrades, Upgrades